Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
366-03-001.
Intratumoral Habitat and Peritumor Radiomics for Progression Risk Stratification of Patients with Soft Tissue Sarcoma
Impact: Combining radiomics features derived from the
intratumoral habitat and peritumoral region resulted in superior performance
for predicting progression-free-survival in patients with STS, which is helpful
for clinical decision making.
|
||
|
366-03-002.
LASSO informed textural changes are more sensitive than volumetry of amygdala in cocaine use disorder patients
Impact: This framework
improves reproducibility and interpretability in longitudinal MRI studies by
integrating penalized regression and mixed-effects modeling, revealing texture
features as temporally sensitive biomarkers of amygdalar microstructure and
treatment-related plasticity beyond conventional volumetric measures in cocaine-use-disorder
patients undergoing treatment.
|
||
|
366-03-003.
DWI, Motion-Corrected T2W, & Free-Breathing 3D-GRE Radiomics for Predicting Neoadjuvant Chemotherapy Efficacy in ESCC
Impact: A non-invasive multimodal MR radiomics model
integrating features from pre- and post-NAC imaging accurately predicts
pathologic response in ESCC patients. This tool can potentially identify
non-responders early, enabling timely treatment modification and facilitating
personalized therapeutic strategies before invasive surgery.
|
||
|
366-03-004.
2.5D deep learning based on multimodal and multi-view MRI predicts recurrence-free survival after radical resection of HCC
Impact: This study aids clinicians in stratifying post-HCC-resection recurrence risk and formulating personalized treatment plans, advances the clinical translation of deep learning, guides researchers in exploring multimodal 2.5D models, and enables further research focusing on the model’s applicability in multicenter data.
|
||
|
366-03-005.
Can AI help radiologists with prostate MRI interpretation?
Impact: AI may
help improve the interpretation of prostate MRI. This study will evaluate the
effect of AI on inter-reader variability and reader accuracy. Future directions
include further development of AI models and radiologist education about AI.
|
||
|
366-03-006.
Preoperative phenotypic stratification of primary central nervous system lymphoma using multiparametric MRI-based radiomics
Impact: An automated multiparametric MRI–based radiomics approach predicts double-expression and germinal center B-cell–like phenotypes of primary central nervous system lymphoma, providing a practical, noninvasive tool for preoperative risk stratification and to inform therapeutic decision-making.
|
||
|
366-03-007.
Prediction of Neoadjuvant Response of Breast Cancer using Pharmacokinetic Quantification of Pre-treatment DCE MRI
Impact: This framework enables more accurate prediction of breast cancer
treatment response by integrating pharmacokinetic quantification in deep
learning and multi-scale radiomics. It may assist clinicians in early therapy
evaluation, optimize treatment decisions, and inspire broader use of
temporal-spatial analysis.
|
||
|
366-03-008.
Distinguishing Atypical Nasopharyngeal Lymphoid Hyperplasia from Early Nasopharyngeal Carcinoma Using MR Habitat Radiomics
Impact: This habitat radiomics tool could reduce unnecessary biopsies for
patients and improve diagnostic consistency for clinicians. It also enables new
research into how spatial tumor heterogeneity influences early cancer
detection.
|
||
|
366-03-009.
Spatiotemporal Delta Radiomics for Predicting Axillary Lymph Node Metastasis in Breast Cancer
Impact:
Delta-radiomics features from DCE-MRI wash-in and wash-out dynamics serve as promising biomarkers for noninvasive ALNM prediction. |
||
|
366-03-010.
Development of MRI-based radiomics model for age-adjusted detection of disease in a preclinical blood cancer models
Impact: We demonstrate that incorporating age-adjusted radiomic feature selection significantly mitigates demographic bias in AI-based AML classification while preserving diagnostic-grade performance, thereby addressing key fairness considerations for the clinical deployment of medical imaging AI across diverse patient populations.
|
© 2026 International Society for Magnetic Resonance in Medicine